Linking the gut microbiota to persistent symptoms in survivors of COVID-19 after dischargeOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study investigated the gut microbiota of people recovering from COVID-19 and examined whether specific bacterial taxa correlated with persistent symptoms after hospital discharge. Stool samples were collected three months after discharge and analyzed using 16S rRNA gene sequencing. The researchers compared bacterial diversity and relative abundance between recovered patients and healthy controls, then tested correlations between individual bacterial taxa and reported symptoms such as fatigue, myalgia, chest tightness, anorexia, and cough.
Who was studied?
The study population consisted of 15 recovered healthcare workers (HCWs) who had been diagnosed with COVID-19, sampled three months after their hospital discharge. A comparison group of 14 healthy controls (HCs) provided stool samples over the same period, between May and July 2020. Both groups underwent 16S rRNA gene sequencing of their fecal microbiota.
What were the most important findings?
Recovered HCWs had reduced bacterial diversity three months after discharge compared with healthy controls, along with a significantly higher relative abundance of opportunistic pathogens and a significantly lower relative abundance of beneficial bacteria. Escherichia unclassified was positively correlated with fatigue, chest tightness after activity, and myalgia, while Intestinibacter bartlettii was positively correlated with anorexia and fatigue. In contrast, Faecalibacterium prausnitzii was negatively correlated with chest tightness after activity, and Intestinimonas butyriciproducens (a butyrate producer) was negatively correlated with cough.
What are the greatest implications of this study?
The findings suggest that gut microbiota alterations persist for months after COVID-19 recovery and are linked to ongoing physical symptoms, not just acute illness. The inverse correlations involving Faecalibacterium prausnitzii and the butyrate producer Intestinimonas butyriciproducens point toward a possible protective or anti-inflammatory role for these commensals against certain post-discharge symptoms. The authors conclude that gut microbiota may play an important role in the recovery process of COVID-19 patients, raising the possibility that microbiome status could help explain, or eventually be targeted to address, persistent post-COVID symptoms.